Lv2
128 积分 2022-05-21 加入
Mechanisms of resistance against T-cell engaging bispecific antibodies in multiple myeloma: implications for novel treatment strategies
8天前
已完结
Discovery and preclinical evaluations of drug candidate DA-0157 capable of overcoming EGFR drug-resistant mutation C797S and EGFR/ALK co-mutations
1个月前
已完结
CDK inhibitors from past to present: A new wave of cancer therapy
1个月前
已完结
Discovery of a potent and selective proteolysis targeting chimera (PROTAC) degrader of NSD3 histone methyltransferase
1个月前
已完结
Synthetic Approaches and Clinical Applications of Representative HDAC Inhibitors for Cancer Therapy: A Review
2个月前
已完结
Recent advances in immunotherapy for small cell lung cancer
2个月前
已完结
Facts and Hopes on Cancer Immunotherapy for Small Cell Lung Cancer
3个月前
已完结
Brief report: Ivonescimab combined with etoposide plus carboplatin as first-line treatment for extensive-stage small-cell lung cancer: results of a phase Ib clinical trial
3个月前
已完结
Discovery and Characterisation of Highly Cooperative FAK‐Degrading PROTACs
4个月前
已完结
Cancer-targeting antibody–drug conjugates drive dealmaking frenzy
7个月前
已完结
皖公网安备34019202002308
